chloroquine has been researched along with suramin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figadère, B; Fournet, A; Franck, X; Hocquemiller, R; Mahieux, R; Prina, E | 1 |
| Berger, H; Brun, R; Kaiser, M; Saf, R; Seebacher, W; Weis, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alvarez, DE; Boiani, L; Bollini, M; Bruno, AM; Casal, JJ; Cerecetto, H; González, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Büchold, C; Gelhaus, C; Gut, J; Kisker, C; Leippe, M; Leyh, M; Machon, U; Rosenthal, PJ; Schirmeister, T; Schmuck, C; Stempka, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Breuning, A; Büchold, C; Degel, B; Gelhaus, C; Gut, J; Heppner, S; Kisker, C; Leippe, M; Leyh, M; Machon, U; Rath, J; Rosenthal, PJ; Schirmeister, T; Schmuck, C; Schulz, F; Stempka, M; Stich, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Haiech, J; Hibert, M; Kellenberger, E; Kuhn, I; Lobstein, A; Muller-Steffner, H; Rognan, D; Said-Hassane, F; Schuber, F; Villa, P | 1 |
| Anklin, C; Bahar, M; Deng, Y; Doskotch, RW; Drew, ME; Gil, RR; He, S; Kinghorn, AD; Navarro-Vázquez, A; Pandharkar, T; Werbovetz, KA; Zhu, X | 1 |
| Agarwal, H; Bahar, M; Brun, R; Cason, E; Doskotch, RW; Drew, ME; Endeshaw, M; He, S; Kaiser, M; Kinghorn, AD; Li, C; Mahasenan, KV; Munde, M; Pandharkar, T; Werbovetz, KA; Wilson, WD; Zhu, X | 1 |
| Ariën, KK; Augustyns, K; Cos, P; Dirié, B; Heeres, J; Joossens, J; Lewi, PJ; Lyssens, S; Maes, L; Michiels, J; Van der Veken, P; Vanham, G; Venkatraj, M | 1 |
| Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
| Amata, E; Devine, W; Erath, J; Lee, PJ; Leed, SE; Mensa-Wilmot, K; Patel, G; Pollastri, MP; Rodriguez, A; Roncal, NE; Sciotti, RJ; Swaminathan, U; Woodring, JL | 1 |
| Mattock, NM; Peters, W | 1 |
| Buyst, H | 1 |
| Courtois, Y; Mascarelli, F; Tassin, J | 1 |
| Flesch, IE; Kaufmann, SH | 1 |
| Barrett-Connor, E | 1 |
| Busch, U; Korolenko, TA; Schneider, P | 1 |
| Martins, IJ; Redgrave, TG; Vermeulen, R | 1 |
| HARTENSTEIN, H; KALLEE, E | 1 |
| TELLA, A | 1 |
2 review(s) available for chloroquine and suramin
| Article | Year |
|---|---|
Drugs for the treatment of parasitic infection.
Topics: Antimony; Bithionol; Chloroquine; Diethylcarbamazine; Humans; Mebendazole; Melarsoprol; Metronidazole; Niclosamide; Niridazole; Oxamniquine; Parasitic Diseases; Pentamidine; Piperazines; Primaquine; Pyrantel Pamoate; Pyrimethamine; Suramin; Thiabendazole; Trichlorfon | 1982 |
A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
Topics: Animals; Chloroquine; Humans; Hypolipidemic Agents; Lipid Metabolism; Liver; Lysosomes; Metals; Suramin; Vinblastine | 1997 |
24 other study(ies) available for chloroquine and suramin
| Article | Year |
|---|---|
Biological evaluation of substituted quinolines.
Topics: Animals; Antiparasitic Agents; Cell Line; Cell Transformation, Viral; Evaluation Studies as Topic; HTLV-I Infections; Leishmania; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Trypanosoma | 2004 |
Antiprotozoal activities of new bis-chlorophenyl derivatives of bicyclic octanes and aza-nonanes.
Topics: Animals; Antiprotozoal Agents; Bridged Bicyclo Compounds, Heterocyclic; In Vitro Techniques; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Topics: Animals; Chagas Disease; DNA, Protozoan; Dose-Response Relationship, Drug; Glutathione; HeLa Cells; Humans; Imidazoles; Isoquinolines; Models, Molecular; Oxidation-Reduction; Quantitative Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences.
Topics: Amino Acid Sequence; Animals; Antiprotozoal Agents; Cathepsin L; Cathepsins; Cattle; Combinatorial Chemistry Techniques; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Diamide; Drug Evaluation, Preclinical; Fumarates; Humans; Peptide Library; Plasmodium falciparum | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids.
Topics: Antimalarials; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
Topics: ADP-ribosyl Cyclase 1; Animals; Binding Sites; Catalytic Domain; Computer Simulation; Enzyme Inhibitors; Flavonoids; High-Throughput Screening Assays; Humans; NAD+ Nucleosidase; Schistosoma mansoni; Schistosomicides; Structure-Activity Relationship | 2010 |
Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Topics: Animals; Antiprotozoal Agents; Berberine; Chlorocebus aethiops; Disease Models, Animal; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Malaria; Mice; Models, Molecular; Parasites; Plasmodium falciparum; Protozoan Infections; Trypanosoma brucei brucei; Trypanosomiasis; Vero Cells | 2011 |
8,8-dialkyldihydroberberines with potent antiprotozoal activity.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Berberine Alkaloids; Crystallography, X-Ray; Female; Inhibitory Concentration 50; Leishmania donovani; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma | 2013 |
From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
Topics: Anti-HIV Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense | 2014 |
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Growth Inhibitors; Hep G2 Cells; Humans; Parasites; Quinazolines | 2015 |
The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antimalarials; Antimony; Antiprotozoal Agents; Ascitic Fluid; Cell Line; Chloroquine; Cricetinae; Culture Techniques; Dogs; Drug Evaluation, Preclinical; Folic Acid Antagonists; Leishmania; Niridazole; Pentamidine; Primaquine; Quinacrine; Quinine; Sarcoma; Sulfonamides; Sulfones; Suramin | 1975 |
The treatment of T. rhodesiense sleeping sickness, with special reference to its physio-pathological and epidemiological basis.
Topics: Arsenicals; Chloroquine; Humans; Melarsoprol; Proguanil; Suramin; Trypanosomiasis, African; Zambia | 1975 |
Effect of FGFs on adult bovine Muller cells: proliferation, binding and internalization.
Topics: Animals; Binding, Competitive; Cattle; Cell Division; Cells, Cultured; Chloroquine; Cross-Linking Reagents; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Heparin; Neuroglia; Phorbol Esters; Protamines; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor; Retina; Suramin | 1991 |
Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages.
Topics: Animals; Antibiosis; Bone Marrow Cells; Butylamines; Chloroquine; Female; Free Radicals; Interferon-gamma; Macrophage Activation; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Mycobacterium tuberculosis; Oxygen; Polyglutamic Acid; Recombinant Proteins; Suramin; Tetracaine | 1988 |
Relative roles of mitochondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test.
Topics: Administration, Oral; Animals; Breath Tests; Carbon Dioxide; Carbon Isotopes; Chloroquine; Cholesterol Esters; Chylomicrons; Epoxy Compounds; Fat Emulsions, Intravenous; Fatty Acids; Hepatectomy; Hydrolysis; Lactoferrin; Liver; Lysosomes; Male; Mice; Mice, Inbred C57BL; Mitochondria; Oxidation-Reduction; Peroxisomes; Propionates; Rats; Rats, Wistar; Suramin | 2000 |
[The effect of germanin and chloroquine (resochin) on iodine-131 metabolism in the rat].
Topics: Animals; Chloroquine; Iodine; Iodine Radioisotopes; Rats; Suramin | 1960 |
CHEMOTHERAPY OF TROPICAL DISEASES.
Topics: Amebiasis; Amebicides; Anti-Bacterial Agents; Antimalarials; Antimony; Arsenicals; Chagas Disease; Chloroquine; Dysentery, Amebic; Emetine; Humans; Iodoquinol; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Malaria; Suramin; Trypanosomiasis; Trypanosomiasis, African; United States | 1964 |